Harris Rotman
Algemeen Adviseur bij CENTESSA PHARMACEUTICALS PLC
Vermogen: 540 454 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Harris Rotman
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Harris Rotman via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Human Resources Officer | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Human Resources Officer Director of Finance/CFO | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Human Resources Officer | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Director/Board Member | |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TESARO INC | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Undergraduate Degree | |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Medical Specialties | Corporate Officer/Principal | |
Gene Trak Systems
 Gene Trak Systems Medical SpecialtiesHealth Technology Part of Neogen Corp., Gene Trak Systems is an American company that provides food testing services using innovative DNA probe-based products for bacterial contaminants. Gene Trak Systems was acquired by Neogen Corp. from Abbott Molecular, Inc. on August 06, 2001 for $3.50 million. | Medical Specialties | Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
Vysis Sarl
 Vysis Sarl Medical DistributorsDistribution Services Part of Applied Genetic Services Ltd., Vysis Sarl is a French company that distributes pharmaceutical products. Vysis was acquired by Applied Genetic Services Ltd. from Abbott Molecular, Inc. on February 08, 2000 for $1.27 million. | Medical Distributors | Chief Operating Officer | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| Lehigh University | College/University | Undergraduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Undergraduate Degree Undergraduate Degree | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| Living Beyond Breast Cancer | Director/Board Member | ||
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree | |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder Founder Private Equity Investor | |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Schering-Plough SAS
 Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Thorell Consulting
 Thorell Consulting Miscellaneous Commercial ServicesCommercial Services Thorell Consulting provides business consulting services. The private company is based in New York. | Miscellaneous Commercial Services | President | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director of Finance/CFO | |
BioMed Valley Discoveries, Inc.
 BioMed Valley Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services BioMed Valley Discoveries, Inc. is a biotechnology company that develops therapies for cancer, inflammation, and infectious disease. The private company is based in Kansas City, MO. The company was founded by Saurabh Saha. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
Critical Pressure Ltd.
 Critical Pressure Ltd. Pharmaceuticals: MajorHealth Technology Critical Pressure Ltd. engages in research and experimental development on biotechnology. The firm develops products to treat vascular dysfunction and shock. The company is headquartered in Babraham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Pharmaceuticals: Generic | Director/Board Member | |
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Université Paris-Saclay | College/University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 33 |
| Verenigd Koninkrijk | 11 |
| Frankrijk | 6 |
| Japan | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 34 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Distribution Services | 2 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 139 |
| Corporate Officer/Principal | 65 |
| Independent Dir/Board Member | 28 |
| Founder | 27 |
| Undergraduate Degree | 21 |
Sterkste connecties
| Insiders | |
|---|---|
| Francesco de Rubertis | 36 |
| David Grainger | 29 |
| Mary Lynne Hedley | 25 |
| Brett Zbar | 23 |
| Gregory Mark Weinhoff | 21 |
| Aaron Kantoff | 19 |
| Arjun Goyal | 16 |
| Saurabh Saha | 16 |
| Joshua D. Hamermesh | 14 |
| Thomas S. Templeman | 14 |
| Ann Thorell | 13 |
| Karen Anderson | 12 |
| Samarth Kulkarni | 11 |
| Carol Stuckley | 10 |
| David Chao | 10 |
- Beurs
- Insiders
- Harris Rotman
- Bedrijfsconnecties
